Featured Webinars

  1. Why Disclosure As A Service? 6/3/2020

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

  2. Sponsors' Advice On Disclosure As A Service 6/3/2020

    Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.

  3. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

  4. PLS Perspectives: Sponsor, Author & Regulatory Viewpoints 2/24/2020

    In this informative webinar, Jazz Pharmaceuticals will provide tips on launching a PLS program. A medical writer from ClaritiDox will give an overview of PLS best practices. And TrialScope’s chief strategy officer will share – and analyze – results from TrialScope’s recent PLS survey.

  5. Disclosure & Transparency Trends Webinar 1/15/2020

    Hear results from TrialScope’s 2019 Global Clinical Trial Disclosure & Transparency Benchmark Survey, highlights from our Plain Language Summaries Survey, and predictions for 2020.

  6. Trends In Clinical Transparency Policies 1/15/2020

    More and more sponsors are making their clinical trial transparency policy publicly available, says TrialScope Chief Strategy Officer Thomas Wicks. Hear additional disclosure and transparency trends.

  7. Importance And Requirements Of Study Results Posting 1/15/2020

    In addition to laws requiring disclosure of clinical trial results, the public also demands this information. TrialScope Chief Strategy Officer Thomas Wicks explains why sponsors should share study results.

  8. An Innovative Approach To Trial Results Summaries 12/3/2019

    See how sponsors are employing technology to replace outdated, paper-based patient communications about trial results. This innovative approach enables clinical trial sponsors to meet their ethical obligations to trial participants while simultaneously increasing patient engagement.

  9. Improving The Quality Of Submitted Studies To ClinicalTrials.gov 11/7/2019

    Want to reduce QC comments? Hear tips from Dr. Deborah Zarin, former director of ClinicalTrials.gov, now with the MRCT Center. Dr. Zarin was keynote speaker at the recent EXTRA: TrialScope Transparency Experience.

  10. Keys To Successful Clinical Trial Data Handling And Re-use 11/7/2019

    In this video, Matt DeFranco, TrialScope Director of Solution Engineering, explains ETL (extract, transform, load) and API (application program interface). He then provides two case studies on their use in clinical trial disclosure and patient engagement.